Canal Insurance CO lowered its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 44.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 50,000 shares of the healthcare product maker's stock after selling